• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

丙型肝炎病毒诱导的肝细胞癌(HCC)中的表观遗传机制

Epigenetic Mechanisms Involved in HCV-Induced Hepatocellular Carcinoma (HCC).

作者信息

Zhao Pin, Malik Samiullah, Xing Shaojun

机构信息

Guandong Key Laboratory for Biomedical Measurements and Ultrasound Imaging, School of Biomedical Engineering, Shenzhen University Health Science Center, Shenzhen, China.

Department of Pathogen Biology, Shenzhen University Health Science Center, Shenzhen, China.

出版信息

Front Oncol. 2021 Jul 15;11:677926. doi: 10.3389/fonc.2021.677926. eCollection 2021.

DOI:10.3389/fonc.2021.677926
PMID:34336665
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8320331/
Abstract

Hepatocellular carcinoma (HCC), is the third leading cause of cancer-related deaths, which is largely caused by virus infection. About 80% of the virus-infected people develop a chronic infection that eventually leads to liver cirrhosis and hepatocellular carcinoma (HCC). With approximately 71 million HCV chronic infected patients worldwide, they still have a high risk of HCC in the near future. However, the mechanisms of carcinogenesis in chronic HCV infection have not been still fully understood, which involve a complex epigenetic regulation and cellular signaling pathways. Here, we summarize 18 specific gene targets and different signaling pathways involved in recent findings. With these epigenetic alterations requiring histone modifications and DNA hyper or hypo-methylation of these specific genes, the dysregulation of gene expression is also associated with different signaling pathways for the HCV life cycle and HCC. These findings provide a novel insight into a correlation between HCV infection and HCC tumorigenesis, as well as potentially preventable approaches. Hepatitis C virus (HCV) infection largely causes hepatocellular carcinoma (HCC) worldwide with 3 to 4 million newly infected cases diagnosed each year. It is urgent to explore its underlying molecular mechanisms for therapeutic treatment and biomarker discovery. However, the mechanisms of carcinogenesis in chronic HCV infection have not been still fully understood, which involve a complex epigenetic regulation and cellular signaling pathways. Here, we summarize 18 specific gene targets and different signaling pathways involved in recent findings. With these epigenetic alterations requiring histone modifications and DNA hyper or hypo-methylation of these specific genes, the dysregulation of gene expression is also associated with different signaling pathways for the HCV life cycle and HCC. These findings provide a novel insight into a correlation between HCV infection and HCC tumorigenesis, as well as potentially preventable approaches.

摘要

肝细胞癌(HCC)是癌症相关死亡的第三大主要原因,主要由病毒感染引起。约80%的病毒感染者会发展为慢性感染,最终导致肝硬化和肝细胞癌(HCC)。全球约有7100万丙型肝炎病毒(HCV)慢性感染患者,他们在不久的将来仍有很高的患HCC风险。然而,慢性HCV感染中的致癌机制仍未完全了解,这涉及复杂的表观遗传调控和细胞信号通路。在此,我们总结了近期研究结果中涉及的18个特定基因靶点和不同信号通路。由于这些表观遗传改变需要组蛋白修饰以及这些特定基因的DNA高甲基化或低甲基化,基因表达的失调也与HCV生命周期和HCC的不同信号通路相关。这些发现为HCV感染与HCC肿瘤发生之间的关联以及潜在的可预防方法提供了新的见解。丙型肝炎病毒(HCV)感染在全球范围内是肝细胞癌(HCC)的主要病因,每年有300万至400万新感染病例被诊断出来。探索其潜在分子机制以用于治疗和生物标志物发现迫在眉睫。然而,慢性HCV感染中的致癌机制仍未完全了解,这涉及复杂的表观遗传调控和细胞信号通路。在此,我们总结了近期研究结果中涉及的18个特定基因靶点和不同信号通路。由于这些表观遗传改变需要组蛋白修饰以及这些特定基因的DNA高甲基化或低甲基化,基因表达的失调也与HCV生命周期和HCC的不同信号通路相关。这些发现为HCV感染与HCC肿瘤发生之间的关联以及潜在的可预防方法提供了新的见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3448/8320331/f31d07d646be/fonc-11-677926-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3448/8320331/552433f31335/fonc-11-677926-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3448/8320331/f31d07d646be/fonc-11-677926-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3448/8320331/552433f31335/fonc-11-677926-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3448/8320331/f31d07d646be/fonc-11-677926-g002.jpg

相似文献

1
Epigenetic Mechanisms Involved in HCV-Induced Hepatocellular Carcinoma (HCC).丙型肝炎病毒诱导的肝细胞癌(HCC)中的表观遗传机制
Front Oncol. 2021 Jul 15;11:677926. doi: 10.3389/fonc.2021.677926. eCollection 2021.
2
Epigenetic mechanism involved in the HBV/HCV-related hepatocellular carcinoma tumorigenesis.参与HBV/HCV相关肝细胞癌肿瘤发生的表观遗传机制。
Curr Pharm Des. 2014;20(11):1715-25. doi: 10.2174/13816128113199990533.
3
Hepatitis C virus leaves an epigenetic signature post cure of infection by direct-acting antivirals.丙型肝炎病毒在直接作用抗病毒药物治愈感染后留下表观遗传特征。
PLoS Genet. 2019 Jun 19;15(6):e1008181. doi: 10.1371/journal.pgen.1008181. eCollection 2019 Jun.
4
A comprehensive genome-wide profiling comparison between HBV and HCV infected hepatocellular carcinoma.HBV 和 HCV 感染的肝细胞癌的全基因组谱比较分析。
BMC Med Genomics. 2019 Oct 28;12(1):147. doi: 10.1186/s12920-019-0580-x.
5
Hepatitis C virus-related hepatocellular carcinoma: An insight into molecular mechanisms and therapeutic strategies.丙型肝炎病毒相关肝细胞癌:对分子机制和治疗策略的深入洞察。
World J Hepatol. 2012 Dec 27;4(12):342-55. doi: 10.4254/wjh.v4.i12.342.
6
Study of promoter hypomethylation profiles of RAS oncogenes in hepatocellular carcinoma derived from hepatitis C virus genotype 3a in Pakistani population.巴基斯坦丙型肝炎病毒 3a 型来源的肝细胞癌中 RAS 癌基因启动子低甲基化谱的研究。
J Med Virol. 2018 Sep;90(9):1516-1523. doi: 10.1002/jmv.25221. Epub 2018 Jun 11.
7
Genetic and epigenetic signatures in human hepatocellular carcinoma: a systematic review.人类肝细胞癌中的遗传和表观遗传特征:一项系统综述。
Curr Genomics. 2011 Apr;12(2):130-7. doi: 10.2174/138920211795564359.
8
DNA methylation of individual repetitive elements in hepatitis C virus infection-induced hepatocellular carcinoma.丙型肝炎病毒感染诱导的肝细胞癌中个体重复元件的 DNA 甲基化。
Clin Epigenetics. 2019 Oct 21;11(1):145. doi: 10.1186/s13148-019-0733-y.
9
Tracking Down the Epigenetic Footprint of HCV-Induced Hepatocarcinogenesis.探寻丙型肝炎病毒诱导肝癌发生的表观遗传印记
J Clin Med. 2021 Feb 2;10(3):551. doi: 10.3390/jcm10030551.
10
Epigenetic mechanisms in hepatocellular carcinoma: how environmental factors influence the epigenome.肝细胞癌中的表观遗传机制:环境因素如何影响表观基因组。
Mutat Res. 2011 May-Jun;727(3):55-61. doi: 10.1016/j.mrrev.2011.04.001. Epub 2011 Apr 15.

引用本文的文献

1
The role of pioneering transcription factors, chromatin accessibility and epigenetic reprogramming in oncogenic viruses.先驱转录因子、染色质可及性和表观遗传重编程在致癌病毒中的作用。
Front Microbiol. 2025 Jun 16;16:1602497. doi: 10.3389/fmicb.2025.1602497. eCollection 2025.
2
Oncogenic viruses rewire the epigenome in human cancer.致癌病毒在人类癌症中重塑表观基因组。
Front Cell Infect Microbiol. 2025 Jun 10;15:1617198. doi: 10.3389/fcimb.2025.1617198. eCollection 2025.
3
MicroRNA Let-7b-5p Targets IGF1R to Inhibit the Progression of Hepatocellular Carcinoma Through the AKT/mTOR Pathway.

本文引用的文献

1
Timing of DAA Initiation After Curative Treatment and Its Relationship with the Recurrence of HCV-Related HCC.治愈性治疗后直接抗病毒药物(DAA)起始治疗的时机及其与丙型肝炎病毒相关肝细胞癌复发的关系。
J Hepatocell Carcinoma. 2020 Dec 1;7:347-360. doi: 10.2147/JHC.S279657. eCollection 2020.
2
Molecular mechanisms of viral hepatitis induced hepatocellular carcinoma.病毒性肝炎诱导肝细胞癌的分子机制。
World J Gastroenterol. 2020 Oct 14;26(38):5759-5783. doi: 10.3748/wjg.v26.i38.5759.
3
LncRNA CSMD1-1 promotes the progression of Hepatocellular Carcinoma by activating MYC signaling.
微小RNA Let-7b-5p通过AKT/mTOR途径靶向胰岛素样生长因子1受体(IGF1R)以抑制肝细胞癌进展。
Cancer Med. 2025 Jun;14(12):e71000. doi: 10.1002/cam4.71000.
4
NS3 of hepatitis C virus drives hepatocellular carcinoma progression through a novel RNA-interference pathway.丙型肝炎病毒的NS3通过一条新的RNA干扰途径推动肝细胞癌进展。
J Cell Commun Signal. 2025 Apr 12;19(2):e70013. doi: 10.1002/ccs3.70013. eCollection 2025 Jun.
5
Cuproplasia and cuproptosis in hepatocellular carcinoma: mechanisms, relationship and potential role in tumor microenvironment and treatment.肝细胞癌中的铜代谢异常与铜死亡:机制、关系及其在肿瘤微环境和治疗中的潜在作用
Cancer Cell Int. 2025 Apr 9;25(1):137. doi: 10.1186/s12935-025-03683-4.
6
Construction and Validation of a Novel Butyrylation-Related Gene Signature Related to Prognosis, Clinical Implications, and Immune Microenvironment Characterization of Hepatocellular Carcinoma.一种与肝细胞癌预后、临床意义及免疫微环境特征相关的新型丁酰化相关基因特征的构建与验证
ACS Omega. 2025 Jan 18;10(4):3375-3388. doi: 10.1021/acsomega.4c06496. eCollection 2025 Feb 4.
7
Chronic Hepatitis C Infection Treated with Direct-Acting Antiviral Agents and Occurrence/Recurrence of Hepatocellular Carcinoma: Does It Still Matter?直接作用抗病毒药物治疗慢性丙型肝炎感染与肝细胞癌的发生/复发:这仍然重要吗?
Viruses. 2024 Dec 10;16(12):1899. doi: 10.3390/v16121899.
8
Mex3a promoter hypomethylation can be utilized to diagnose HBV-associated hepatocellular carcinoma: a randomized controlled trial.Mex3a启动子低甲基化可用于诊断乙肝病毒相关肝细胞癌:一项随机对照试验。
Front Pharmacol. 2024 Nov 5;15:1325869. doi: 10.3389/fphar.2024.1325869. eCollection 2024.
9
Bioinformatics Analysis Reveals CDK1 and DLGAP5 as Key Modulators of Tumor Immune Cell Infiltration in Hepatocellular Carcinoma.生物信息学分析揭示CDK1和DLGAP5是肝细胞癌肿瘤免疫细胞浸润的关键调节因子。
Cancer Manag Res. 2024 Nov 14;16:1597-1608. doi: 10.2147/CMAR.S478426. eCollection 2024.
10
lncRNA POLR2J4 Plays a Biomarker Role in Hepatitis B Virus-Related Hepatocellular Carcinoma Through Regulating miR-214-3p.lncRNA POLR2J4 通过调节 miR-214-3p 在乙型肝炎病毒相关肝细胞癌中发挥生物标志物作用。
Turk J Gastroenterol. 2024 Aug 26;35(10):787-794. doi: 10.5152/tjg.2024.24150.
长链非编码 RNA CSMD1-1 通过激活 MYC 信号促进肝癌的进展。
Theranostics. 2020 Jun 12;10(17):7527-7544. doi: 10.7150/thno.45989. eCollection 2020.
4
FOXA1 Promotes Cell Proliferation and Suppresses Apoptosis in HCC by Directly Regulating miR-212-3p/FOXA1/AGR2 Signaling Pathway.FOXA1通过直接调控miR-212-3p/FOXA1/AGR2信号通路促进肝癌细胞增殖并抑制其凋亡。
Onco Targets Ther. 2020 Jun 9;13:5231-5240. doi: 10.2147/OTT.S252890. eCollection 2020.
5
MTL-CEBPA, a Small Activating RNA Therapeutic Upregulating C/EBP-α, in Patients with Advanced Liver Cancer: A First-in-Human, Multicenter, Open-Label, Phase I Trial.MTL-CEBPA,一种上调C/EBP-α的小激活RNA疗法,用于晚期肝癌患者:一项首次人体、多中心、开放标签的I期试验。
Clin Cancer Res. 2020 Aug 1;26(15):3936-3946. doi: 10.1158/1078-0432.CCR-20-0414. Epub 2020 May 1.
6
Hepatitis C Virus and Hepatocellular Carcinoma: When the Host Loses Its Grip.丙型肝炎病毒与肝细胞癌:当宿主失去控制之时
Int J Mol Sci. 2020 Apr 26;21(9):3057. doi: 10.3390/ijms21093057.
7
Hepatocellular Carcinoma Mechanisms Associated with Chronic HCV Infection and the Impact of Direct-Acting Antiviral Treatment.与慢性丙型肝炎病毒感染相关的肝细胞癌机制及直接抗病毒治疗的影响
J Hepatocell Carcinoma. 2020 Apr 15;7:45-76. doi: 10.2147/JHC.S221187. eCollection 2020.
8
LncRNAs in HCV Infection and HCV-Related Liver Disease.长链非编码 RNA 在 HCV 感染和 HCV 相关肝病中的作用。
Int J Mol Sci. 2020 Mar 24;21(6):2255. doi: 10.3390/ijms21062255.
9
Epigenetics of : The Dual Roles in Human Cancers.表观遗传学:在人类癌症中的双重作用。 (注:原文标题表述不太完整规范,推测完整标题可能类似这样,根据实际情况可能需要调整)
Cancers (Basel). 2020 Feb 14;12(2):445. doi: 10.3390/cancers12020445.
10
Circulatory miRNA-484, 524, 615 and 628 expression profiling in HCV mediated HCC among Egyptian patients; implications for diagnosis and staging of hepatic cirrhosis and fibrosis.埃及患者中丙型肝炎病毒介导的肝癌患者循环miRNA - 484、524、615和628表达谱分析;对肝硬化和肝纤维化诊断及分期的意义
J Adv Res. 2019 Dec 24;22:57-66. doi: 10.1016/j.jare.2019.12.002. eCollection 2020 Mar.